KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Gains from Investment Securities: 2020-2025

Historic Gains from Investment Securities for Hims & Hers Health (HIMS) over the last 6 years, with Sep 2025 value amounting to $69.4 million.

  • Hims & Hers Health's Gains from Investment Securities rose 541.73% to $69.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.2 million, marking a year-over-year increase of 310.46%. This contributed to the annual value of $52.5 million for FY2024, which is 272.45% up from last year.
  • As of Q3 2025, Hims & Hers Health's Gains from Investment Securities stood at $69.4 million, which was up 532.37% from $11.0 million recorded in Q2 2025.
  • Hims & Hers Health's Gains from Investment Securities' 5-year high stood at $69.4 million during Q3 2025, with a 5-year trough of -$758,000 in Q4 2021.
  • Moreover, its 3-year median value for Gains from Investment Securities was $10.8 million (2024), whereas its average is $18.1 million.
  • Examining YoY changes over the last 5 years, Hims & Hers Health's Gains from Investment Securities showed a top increase of 5,322.73% in 2021 and a maximum decrease of 205.57% in 2021.
  • Quarterly analysis of 5 years shows Hims & Hers Health's Gains from Investment Securities stood at -$758,000 in 2021, then spiked by 302.77% to $1.5 million in 2022, then surged by 159.92% to $4.0 million in 2023, then surged by 385.73% to $19.4 million in 2024, then skyrocketed by 541.73% to $69.4 million in 2025.
  • Its Gains from Investment Securities stands at $69.4 million for Q3 2025, versus $11.0 million for Q2 2025 and $52.5 million for Q1 2025.